GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » Intrinsic Value: Projected FCF

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Intrinsic Value: Projected FCF : $0.00 (As of Jun. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-14), Arbor Rapha Capital Bioholdings I's Intrinsic Value: Projected FCF is $0.00. The stock price of Arbor Rapha Capital Bioholdings I is $11.90. Therefore, Arbor Rapha Capital Bioholdings I's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Arbor Rapha Capital Bioholdings I's Intrinsic Value: Projected FCF or its related term are showing as below:

ARCK's Price-to-Projected-FCF is not ranked *
in the Diversified Financial Services industry.
Industry Median: 0.87
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Arbor Rapha Capital Bioholdings I Intrinsic Value: Projected FCF Historical Data

The historical data trend for Arbor Rapha Capital Bioholdings I's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbor Rapha Capital Bioholdings I Intrinsic Value: Projected FCF Chart

Arbor Rapha Capital Bioholdings I Annual Data
Trend Dec21
Intrinsic Value: Projected FCF
-

Arbor Rapha Capital Bioholdings I Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Intrinsic Value: Projected FCF Get a 7-Day Free Trial - - - - -

Competitive Comparison of Arbor Rapha Capital Bioholdings I's Intrinsic Value: Projected FCF

For the Shell Companies subindustry, Arbor Rapha Capital Bioholdings I's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arbor Rapha Capital Bioholdings I's Price-to-Projected-FCF Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Arbor Rapha Capital Bioholdings I's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Arbor Rapha Capital Bioholdings I's Price-to-Projected-FCF falls into.



Arbor Rapha Capital Bioholdings I Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Arbor Rapha Capital Bioholdings I  (NAS:ARCK) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Arbor Rapha Capital Bioholdings I's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=11.90/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arbor Rapha Capital Bioholdings I Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Traded in Other Exchanges
N/A
Address
333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553
Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Ralph Mack director 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin director, officer: Chief Strategy Officer C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio officer: Chief Financial Officer C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone officer: Treasurer C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly officer: Secretary & Vice President C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker director C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc director, 10 percent owner, officer: Chief Executive Officer 333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin director C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines